Technology

Biomedical engineer’s innovative excellence acknowledged

Published

1 year ago

February 5, 2025

ADELAIDE, Australia, Feb. 5, 2025 /PRNewswire/ — University of Adelaide Associate Professor Jiawen Li has been awarded a prestigious global award by tech giant Sony and scientific publishing company Nature, for her work in biomedical engineering.

Associate Professor Li, who works at the University’s School of Electrical and Mechanical Engineering and Institute for Photonics and Advanced Sensing, is the only person in Australia and one of only four women innovators worldwide to be recognised in the inaugural Sony Women in Technology Award with Nature.

After receiving high-calibre applications, the judges’ panel decided to extend a special Judges’ Commendation recognition to Associate Professor Li, an early-career researcher who is leading the University’s multimodal imaging and sensing program.

Associate Professor Li said it was a great honour to accept the award and acknowledged all the people who have supported her endeavours.

“My work involves using cutting-edge engineering techniques to address complex biomedical challenges,” said Associate Professor Li.

“In this field, collaboration is key. Through close collaboration with clinicians, biologists, physicists, chemists, and engineers from diverse backgrounds, we can identify critical unmet needs in medicine and develop highly innovative, practical, and deployable solutions.”

“Throughout my career, I’ve been fortunate to have incredible mentors, both women and men, who champion women in STEM. With their guidance and encouragement, I have learnt that I don’t have to ‘make myself invisible’ to fit into a male-dominated environment.”

While the number of women enrolling in university STEM courses is increasing, under representation in STEM-qualified jobs has yet to be redressed.

Associate Professor Li’s work combines nanoscale 3D printing with optical fibre technology to create a hair-thin endoscope that cardiologists can use to investigate blood vessels to determine a patient’s risk for a heart attack. This invention can also be used for prevention and personalised treatments.

Together with her collaborators, Associate Professor Li is also expanding the multimodal technology’s features to measure data like site-specific temperature and chemical changes, as well as exploring applications in neurology and IVF.

Professor Anton Middelberg, Deputy Vice-Chancellor (Research), University of Adelaide, congratulated Associate Professor Li on her award.

“Associate Professor Li’s world-class research is a shining example of the University of Adelaide’s commitment to finding solutions to society’s challenges,” said Professor Middelberg.

“This award adds to Associate Professor Li’s impressive list of achievements and funding which underline the impact of her work.

“Associate Professor Li’s efforts to commercialise her innovative research underlines her commitment to seeing it benefit as many people as possible.

“We are proud to have Associate Professor Li as part of our community of researchers here in Adelaide who make history with each new discovery — accelerating human progress and making our world a better place.”

Associate Professor Li joins Dr Kiana Aran, a professor of bioengineering and medicine at UC San Diego; Dr Amanda Randles, a computational scientist biomedical engineer from Duke University and Dr Yating Wan, an Assistant Professor at King Abdullah University of Science and Technology, (Saudi Arabia) who also received awards.

We launched this award in March 2024 with the clear aim of supporting more diverse gender representation within the international research community,” said Hiroaki Kitano, CTO of Sony Group Corporation and executive sponsor of the program.

“We are very inspired by our honorees, each of them challenging the current state of the art in their fields. We look forward to championing their work, as well as growing the program in the years to come.”

Associate Professor Li received her award at a ceremony at the headquarters of Sony in Tokyo, Japan.

More information is available on the Sony Women in Technology Award with Nature website.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/biomedical-engineers-innovative-excellence-acknowledged-302368258.html

SOURCE University of Adelaide

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

29 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

29 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

29 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated